Search research articles
Contact Us
Filters
Showing results (521-530 of 761) with videos related to
Page
of 77
Sort By:
Clinical Pharmacology and Therapeutics
|
July 20, 2024
Evaluating the Effect of Estimating Renal Function With the CKD-EPI 2021 Equation on the ABCD-GENE Score for Clopidogrel Response Prediction
Maryam Jamal AlSaeed, Cameron D Thomas, Francesco Franchi, et al.
Thrombosis and Haemostasis
|
May 27, 2011
Impact of adjunctive cilostazol therapy on platelet function profiles in patients with and without diabetes mellitus on aspirin and clopidogrel therapy
Dominick J Angiolillo, Piera Capranzano, Jose Luis Ferreiro, et al.
Circulation
|
September 2, 2008
Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38
Stephen D Wiviott, Eugene Braunwald, Dominick J Angiolillo, et al.
Journal of Thrombosis and Thrombolysis
|
May 31, 2015
Impact of cangrelor overdosing on bleeding complications in patients undergoing percutaneous coronary intervention: insights from the CHAMPION trials
Dominick J Angiolillo, Deepak L Bhatt, Ph Gabriel Steg, et al.
Revista Espanola De Cardiologia
|
November 28, 2006
[Efficacy of sirolimus-eluting stent implantation in diabetic patients with very small vessels (< or = 2.25 mm). Insights from the DIABETES trial]
Pilar Jiménez-Quevedo, Manel Sabaté, Dominick J Angiolillo, et al.
Vascular Pharmacology
|
January 31, 2023
Influence of body weight and body mass index on the chronic pharmacokinetic and pharmacodynamic responses to clinically available doses of ticagrelor in patients with chronic coronary syndromes
William A E Parker, Dominick J Angiolillo, Fabiana Rollini, et al.
Circulation. Cardiovascular Interventions
|
May 31, 2015
Cluster-randomized clinical trial examining the impact of platelet function testing on practice: the treatment with adenosine diphosphate receptor inhibitors: longitudinal assessment of treatment patterns and events after acute coronary syndrome prospective open label antiplatelet therapy study
Tracy Y Wang, Timothy D Henry, Mark B Effron, et al.
JACC. Cardiovascular Interventions
|
October 30, 2024
Antithrombotic Therapy in High Bleeding Risk, Part II: Noncardiac Percutaneous Interventions
Mattia Galli, Felice Gragnano, Martina Berteotti, et al.
JACC. Cardiovascular Interventions
|
October 17, 2024
Antithrombotic Therapy in High Bleeding Risk, Part I: Percutaneous Cardiac Interventions
Mattia Galli, Felice Gragnano, Martina Berteotti, et al.
Circulation. Cardiovascular Quality and Outcomes
|
December 12, 2019
Systematic Evaluation of the Robustness of the Evidence Supporting Current Guidelines on Myocardial Revascularization Using the Fragility Index
Mario Gaudino, Irbaz Hameed, Giuseppe Biondi-Zoccai, et al.
Page
of 77
Search research articles
Search
Showing results (521-530 of 761) with videos related to
Sort By:
Page
of 77
Clinical Pharmacology and Therapeutics
|
July 20, 2024
Evaluating the Effect of Estimating Renal Function With the CKD-EPI 2021 Equation on the ABCD-GENE Score for Clopidogrel Response Prediction
Maryam Jamal AlSaeed, Cameron D Thomas, Francesco Franchi, et al.
Thrombosis and Haemostasis
|
May 27, 2011
Impact of adjunctive cilostazol therapy on platelet function profiles in patients with and without diabetes mellitus on aspirin and clopidogrel therapy
Dominick J Angiolillo, Piera Capranzano, Jose Luis Ferreiro, et al.
Circulation
|
September 2, 2008
Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38
Stephen D Wiviott, Eugene Braunwald, Dominick J Angiolillo, et al.
Journal of Thrombosis and Thrombolysis
|
May 31, 2015
Impact of cangrelor overdosing on bleeding complications in patients undergoing percutaneous coronary intervention: insights from the CHAMPION trials
Dominick J Angiolillo, Deepak L Bhatt, Ph Gabriel Steg, et al.
Revista Espanola De Cardiologia
|
November 28, 2006
[Efficacy of sirolimus-eluting stent implantation in diabetic patients with very small vessels (< or = 2.25 mm). Insights from the DIABETES trial]
Pilar Jiménez-Quevedo, Manel Sabaté, Dominick J Angiolillo, et al.
Vascular Pharmacology
|
January 31, 2023
Influence of body weight and body mass index on the chronic pharmacokinetic and pharmacodynamic responses to clinically available doses of ticagrelor in patients with chronic coronary syndromes
William A E Parker, Dominick J Angiolillo, Fabiana Rollini, et al.
Circulation. Cardiovascular Interventions
|
May 31, 2015
Cluster-randomized clinical trial examining the impact of platelet function testing on practice: the treatment with adenosine diphosphate receptor inhibitors: longitudinal assessment of treatment patterns and events after acute coronary syndrome prospective open label antiplatelet therapy study
Tracy Y Wang, Timothy D Henry, Mark B Effron, et al.
JACC. Cardiovascular Interventions
|
October 30, 2024
Antithrombotic Therapy in High Bleeding Risk, Part II: Noncardiac Percutaneous Interventions
Mattia Galli, Felice Gragnano, Martina Berteotti, et al.
JACC. Cardiovascular Interventions
|
October 17, 2024
Antithrombotic Therapy in High Bleeding Risk, Part I: Percutaneous Cardiac Interventions
Mattia Galli, Felice Gragnano, Martina Berteotti, et al.
Circulation. Cardiovascular Quality and Outcomes
|
December 12, 2019
Systematic Evaluation of the Robustness of the Evidence Supporting Current Guidelines on Myocardial Revascularization Using the Fragility Index
Mario Gaudino, Irbaz Hameed, Giuseppe Biondi-Zoccai, et al.
Page
of 77